What is SAPHNELO used for?

( ARTG ) SAPHNELO (anifrolumab) is indicated as add on treatment of adult patients with moderate to severe, active systemic lupus erythematosus (SLE), despite standard therapy.,The safety and efficacy of SAPHNELO have not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus.

What pharmaceutical form is SAPHNELO available in?

SAPHNELO: INJECTION, SOLUTION 120 mg/.8mL (SUBCUTANEOUS)

What are the side effects of SAPHNELO?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can SAPHNELO be used during pregnancy?

( AHT ) For the active ingredient anifrolumab You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

OTC

SAPHNELO

120 mg/.8mL, Injection, solution

INN: ANIFROLUMAB

Data updated: 2026-05-02

Available in:

🇩🇪🇬🇧

Form

INJECTION, SOLUTION

Dosage

120 mg/.8mL

Route

SUBCUTANEOUS

Storage

—

About This Product

Manufacturer

AstraZeneca Pharmaceuticals LP

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.